Danantara Takes $2.5 Billion Stake in JBS Australia and New Zealand Operations
Danantara Indonesia, via Danantara Investment Management, agreed to invest $2.5 billion for a 25% stake in a new joint venture with JBS S.A. valuing the JV at about $10 billion post-money. The JV could deploy up to an additional $2.5 billion. Deal is subject to regulatory approvals. JBS reported FY2025 net sales of $8.08B for Australia and NZ and group net revenue of about $86.2B.
How this was made

The 30-second read
Why it matters
The disclosed $2.5B initial equity and up to $5B total available capital frame a potentially material strategic expansion for the JV, but the deal’s timing and final economics remain contingent on approvals and closing conditions.
Market read
A large JV stake and valuation disclosure can move sentiment around JBS’s regional growth strategy, though traders will likely wait for regulatory and definitive deal terms.
What to watch
The article does not disclose detailed economics (governance, funding mechanics, or expected returns), so traders may discount the impact until filings or definitive terms emerge.
Background
Danantara Indonesia, via Danantara Investment Management, is forming a JV with JBS focused on JBS’s Australia and New Zealand operations, with potential follow-on capital for acquisitions and greenfield projects.
Ticker impact
The article says Danantara will buy a 25% stake in a JV with JBS covering Australia and New Zealand operations, valuing the JV at about $10B post-money.
Moderate positive bias on deal clarity, but magnitude depends on how markets view JV economics and regulatory path.
The text provides deal size, stake, valuation, and scope (50+ facilities), but does not include JBS-specific financial guidance changes or deal terms beyond capital availability and closing conditions.
Market effects
Could signal increased protein capacity and investment in Indonesia and Southeast Asia via JBS’s regional platform.
May support protein supply chain buildout across Indonesia, Southeast Asia, Australia, and New Zealand.
Large cross-border capital commitment may affect investor sentiment toward global meat processing M&A and JV structures.
Counterpoint
Regulatory approvals and customary closing conditions could delay or derail the transaction, limiting near-term certainty.
Key entities
- sovereign wealth fundDanantara Indonesia
Agreed to invest $2.5B for a 25% stake in a newly formed JV tied to JBS’s Australia and New Zealand operations.
- public companyJBS S.A.
Brazilian food giant partnering in the JV; its Australia and New Zealand operations are the stated investment focus.
- investment managerDanantara Investment Management (DIM)
Vehicle through which Danantara makes the initial equity investment.


